Search

Prestige Consumer Healthcare

Fermé

SecteurSoins de santé

48.99 0.95

Résumé

Variation du prix de l'action

24h

Actuel

Min

48.29

Max

50.29

Chiffres clés

By Trading Economics

Revenu

7.2M

54M

Ventes

-1.8M

282M

P/E

Moyenne du Secteur

12.54

62.58

BPA

1.23

Marge bénéficiaire

19.149

Employés

890

EBITDA

4.5M

85M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+46.85% upside

Dividendes

By Acuity

Prochains Résultats

6 août 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-8.7M

2.4B

Ouverture précédente

48.04

Clôture précédente

48.99

Sentiment de l'Actualité

By Acuity

50%

50%

145 / 340 Classement par Healthcare

Prestige Consumer Healthcare Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

21 juil. 2026, 15:41 UTC

Prestige Consumer Healthcare Inc shares are lower today, diverging from broader market strength as no specific news was identified to explain the decline.

20 juil. 2026, 19:52 UTC

Prestige Consumer Healthcare Inc. is trading higher today, recovering from earlier lows. The stock remains near the upper end of its one-month range.

Comparaison

Variation de prix

Prestige Consumer Healthcare prévision

Objectif de Prix

By TipRanks

46.85% hausse

Prévisions sur 12 Mois

Moyen 72 USD  46.85%

Haut 72 USD

Bas 72 USD

Basé sur 3 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

3 ratings

2

Achat

1

Maintien

0

Vente

Sentiment

By Acuity

145 / 340Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and Debrox for ear wax removal. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; Dramamine for motion sickness relief; enemas and other laxative products under the Fleet brand name; Gaviscon for upset stomach; cough drops under the Luden's brand; Monistat for yeast infections in women; Nix for lice and parasite treatments; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; TheraTears for dry eyes; nasal saline sprays and washes under the Fess brand name; and Hydralyte for oral rehydration. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
help-icon Live chat